Background: The ongoing novel coronavirus (COVID-19) pandemic is shaping the world on an unprecedented scale affecting more than 10.3 million individuals across the globe . Various studies have found that C- reactive protein (CRP ) levels could reflect disease severity and should be used as a key indicator for disease monitoring .
Objective:
To assess the level of C reactive protein(CRP) in initial stage of COVID-19 cases and its correla-tion with clinical presentation of disease.
Materials and method:This retrospective case-control study includes 60 RT- PCR (reverse tran-scriptase-polymerase chain reaction) confirmed positive cases above the age of 18 years who were subsequently admitted between May- June, 2020, at Mahendra Mohan Choudhury Hospi-tal(MMCH) –an annexe hospital of Gauhati Medical College and Hospital(GMCH), Kamrup, As-sam.
Result:The mean CRP value in the case group was 6 ± 2.36 mg/L while in control group it was 3.03 ± 1.20 which was found to be significantly raised (p<0.005)
Conclusion: CRP may be an important index for prognosis and assessment of early stage of COVID-19. CRP levels can also be used in the treatment and management of positive cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.